Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$120,000.00
Assessing the potential of targeting the casein kinase 1 (CK1)-like kinase Yck2 to combat antifungal resistance in fungal pathogens
EF 2024-25
Résumé
Fungal pathogens such as Candida albicans are a major threat to human health. Currently, there are only three primary classes of antifungals used for the treatment of systemic fungal infections: azoles, polyenes, and echinocandins. The emergence of resistance coupled with the limited antifungal arsenal highlights the need for novel drugs and targeting fungal kinases is a promising strategy. A previous study revealed a compound termed GW, as an inhibitor of C. albicans yeast casein kinase 2 (Yck2). Yck2 is required for growth under physiological conditions, is important for maintaining antifungal resistance, and plays a key role in virulence in a mouse model of infection. However, the poor stability of GW in a mammalian host makes it unsuitable for further drug development. Therefore, to improve the properties of GW, our interdisciplinary team generated three structurally-different sets of molecules based on the GW parent molecule. Newly-synthesized compounds are tested for antifungal activity and fungal selectivity using both biochemical kinase assays and whole-cell fungal growth assays. Results obtained are used to inform additional rounds of compound optimization. Additionally, this work proposes to study Yck2's role in governing antifungal resistance in C. albicans by identifying downstream targets using biochemical approaches. Ultimately, this project endeavours to characterize novel Yck2 inhibitors, while also elucidating the ways through which Yck2 enables antifungal resistance.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
518329
Name
Yiu Bonnie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Assessing the potential of targeting the casein kinase 1 (CK1)-like kinase Yck2 to combat antifungal resistance in fungal pathogens
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Anti-Virulence; Antifungals; Candida Albicans; Casein Kinase; Drug Development; Drug Resistance; Fungal Pathogens; Kinases Inhibitors
Abstract
Fungal pathogens such as Candida albicans are a major threat to human health. Currently, there are only three primary classes of antifungals used for the treatment of systemic fungal infections: azoles, polyenes, and echinocandins. The emergence of resistance coupled with the limited antifungal arsenal highlights the need for novel drugs and targeting fungal kinases is a promising strategy. A previous study revealed a compound termed GW, as an inhibitor of C. albicans yeast casein kinase 2 (Yck2). Yck2 is required for growth under physiological conditions, is important for maintaining antifungal resistance, and plays a key role in virulence in a mouse model of infection. However, the poor stability of GW in a mammalian host makes it unsuitable for further drug development. Therefore, to improve the properties of GW, our interdisciplinary team generated three structurally-different sets of molecules based on the GW parent molecule. Newly-synthesized compounds are tested for antifungal activity and fungal selectivity using both biochemical kinase assays and whole-cell fungal growth assays. Results obtained are used to inform additional rounds of compound optimization. Additionally, this work proposes to study Yck2's role in governing antifungal resistance in C. albicans by identifying downstream targets using biochemical approaches. Ultimately, this project endeavours to characterize novel Yck2 inhibitors, while also elucidating the ways through which Yck2 enables antifungal resistance.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yiu, Bonnie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~